Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns
FDA urges doctors to avoid implanting new patients with the Zimmer Biomet CPT hip replacement system unless no other alternatives are available.
FDA urges doctors to avoid implanting new patients with the Zimmer Biomet CPT hip replacement system unless no other alternatives are available.
The FDA rejected an effort by Merck to add new Fosamax fracture label warnings in 2009, a federal judge determined.